New York Daily News Johnson & Johnson shut down COVID-19 vaccine production at a plant in the Netherlands that was producing doses earmarked for poorer countries, according to a report.
The facility, in the South Holland city Leiden, has instead shifted to manufacturing a vaccine for a different, unrelated virus that could potentially be more profitable, the New York Times found…
